Cite

HARVARD Citation

    Alarcon-Payer, C. et al. (n.d.). 4CPS-103 Evaluation of health outcomes of daratumumab in monotherapy in adult patients with relapsed refractory multiple myeloma. European journal of hospital pharmacy. p. A116. [Online]. 
  
Back to record